The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Krylov N.N.

Klinika fakul'tetskoĭ khirurgii #1 lechebnogo fakul'teta Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova

Pyatenko E.A.

First Moscow State medical University named after I.M. Sechenov, Moscow, Russia

Komissarov A.B.

First Moscow State medical University named after I.M. Sechenov, Moscow, Russia

Comparative analysis of colorectal cancer screening approaches

Authors:

Krylov N.N., Pyatenko E.A., Komissarov A.B.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2017;(11): 92‑97

DOI: 10.17116/hirurgia20171192-97

Read: 1130 times

Download PDF (RU)
Contact the author
Table of contents

COMPARATIVE ANALYSIS OF COLORECTAL CANCER SCREENING APPROACHES
COMPARATIVE ANALYSIS OF COLORECTAL CANCER SCREENING APPROACHES

To cite this article:

Krylov NN, Pyatenko EA, Komissarov AB. Comparative analysis of colorectal cancer screening approaches. Pirogov Russian Journal of Surgery. 2017;(11):92‑97. (In Russ.)
https://doi.org/10.17116/hirurgia20171192-97

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Comparative analysis of longitudinal and transverse mini­laparotomy during colon cancer surgery. Piro­gov Russian Journal of Surgery. 2025;(4):71-78
Characteristics and diagnostic value of preoperative biopsy in colo­rectal late­rally spreading tumors. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):16-24
Early dete­ction of gastrointestinal cancer: oppo­rtunities for the deve­lopment of endo­scopic services in the Russian Fede­ration. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):69-80
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
On the issue of choosing anesthesia methods: a comparison of gene­ral medi­cine and clinical dentistry. Stomatology. 2025;(1):76-80
A mega­polis school children medi­cal check-up: orga­nizational approaches problems and their solu­tions. Russian Journal of Preventive Medi­cine. 2025;(3):20-25
Prevalence of cere­brovascular diseases risk factors acco­rding to the cohort survey data in Bishkek, Kyrgyz Repu­blic. Russian Journal of Preventive Medi­cine. 2025;(3):34-39
Ergo­spirometry for preoperative risk asse­ssment in patients with colo­rectal cancer. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):70-77
Prevalence of postpartum depression in the Russian Fede­ration: a systematic review and meta-analysis. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):74-87
Guidelines for asse­ssing the quality of mammographic images. Russian Journal of Preventive Medi­cine. 2025;(6):21-32
Abstract:

Keywords:

colorectal cancer
screening
comparative analysis

Authors:

Krylov N.N.

Klinika fakul'tetskoĭ khirurgii #1 lechebnogo fakul'teta Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova

Pyatenko E.A.

First Moscow State medical University named after I.M. Sechenov, Moscow, Russia

Komissarov A.B.

First Moscow State medical University named after I.M. Sechenov, Moscow, Russia

Close metadata

References:

  1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104-117. Epub 2014 Mar 17. https://doi.org/10.3322/caac.21220
  2. Globocan IARC http://globocan.iarc.fr/
  3. Binefa G, Rodríguez-Moranta F, Teule À, Medina-Hayas M. Colorectal cancer: From prevention to personalized medicine. World J Gastroenterol. 2014;20(22):6786-6808.
  4. Gellad ZF, Provenzale D. Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology. 2010;138(6):2177-2190.
  5. Sovich JL, Sartor Z, Misra S. Developments in Screening Tests and Strategies for Colorectal Cancer. Biomed Res Int. 2015;326728.
  6. Barchuk AA, Belyaev AM, Filochkina AV, Arsen’ev AI, Auvinen A. Skrining raka i smertnost’. Prakticheskaya onkologiya. 2016;17:4:228-246. (In Russ.)
  7. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. World Health Organisation, Geneva, Switzerland. 1968.
  8. Karen Simon Colorectal cancer development and advances in screening. Clin Interv Aging. 2016;11:967-976.
  9. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. The New England Journal of Medicine. 1993;328(19):1365-1371. https://doi.org/10.1056/nejm199305133281901
  10. Greegor DH. Occult blood testing for detection of asymptomatic colon cancer. Cancer. 1971;28:131-134.
  11. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171. https://doi.org/10.7326/M13-1484
  12. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. British Journal of Surgery. 2008;95:8:1029-1036.
  13. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008;149(7):441-450.
  14. Itzkowitz S, Brand R, Jandorf L, et al. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol. 2008;103(11):2862-2870.
  15. Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Europ J Cancer. 2013;49:14:3049-3054.
  16. Rabeneck L, Zwaal C, Goodman JH, Mai V, Zamkanei M. Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations. Clin Biochem. 2008;41(16-17):1289-1305.
  17. van Rossum LG, van Rijn AF, van Oijen MG, et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer. 2009;125:746-750. https://doi.org/10.1002/ijc.24458
  18. Parra-Blanco A, Gimeno-García AZ, Quintero E, et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol. 2010;45(7):703-712.
  19. Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, et al. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Aliment Pharmacol Ther. 2010;31(3):432-439.
  20. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99(19):1462-1470.
  21. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146(4):244-255.
  22. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. 1992;256(5053):102-105.
  23. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-1297.
  24. Ahlquist DA, Zou H, Domanico M, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012;142:2:248-256.
  25. Lidgard GP, Domanico MJ, Bruinsma JJ, et al. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clinical Gastroenterology and Hepatology. 2013;11:10:1313-1318.
  26. Fu WP, Kam MH, Ling WM, Ong SF, Suzannah N, Eu KW. Screening for colorectal cancer using a quantitative immunochemical faecal occult blood test: a feasibility study in an Asian population. Tech Coloproctol. 2009;13(3):225-230.
  27. Kung JW, Levine MS, Glick SN, Lakhani P, Rubesin SE, Laufer I. Сolorectal cancer: screening double-contrast barium enema examination in average-risk adults older than 50 years. Radiology. 2006;240:3:725-735.
  28. Chong JN, Shah MS, Levine, et al. Diagnostic yield of barium enema examination after incomplete colonoscopy. Radiology. 2002;223:3:620-624.
  29. Pullens HJ, Siersema PD. Quality indicators for colonoscopy: current insights and caveats. World Journal of Gastrointestinal Endoscopy. 2014;6(12):571-583. https://doi.org/10.4253/wjge.v6.i12.571
  30. Keith L. Obstein and Pietro Valdastri. Advanced endoscopic technologies for colorectal cancer screening. World J Gastroenterol. 2013;19(4): 431-439.
  31. Sovich JL, Sartor Z, Misra S. Developments in Screening Tests and Strategies for Colorectal. Cancer. Biomed Res Int. 2015;326728.
  32. Day LW, Kwon A, Inadomi JM, Walter LC, Somsouk M. Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc. 2011;74:885-896. https://doi.org/10.1016/j.gie.2011.06.02
  33. Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology. 2010;138(6):2115-2126.
  34. Pickhardt PJ, Nugent PA, Mysliwiec PA, Choi JR, Schindler WR. Location of adenomas missed by optical colonoscopy. Ann Intern Med. 2004;141(5):352-359.
  35. Bressler B, Paszat LF, Vinden C, Li C, He J, Rabeneck L. Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology. 2004;127(2):452-456.
  36. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7(7):770-775; quiz 711.
  37. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case—control study. Ann Intern Med. 2011;154(1):22-30.
  38. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1):1-8.
  39. Ko BM. Colon cancer screening with image-enhanced endoscopy. Clinical Endoscopy. 2014;47(6):504-508. https://doi.org/10.5946/ce.2014.47.6.504
  40. Singh H, Penfold RB, DeCoster C, et al. Colonoscopy and its complications across a Canadian regional health authority. Gastrointest Endosc. 2009;69:665-671.
  41. Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection — systematic review and meta-analysis. Radiology. 2011;259(2):393-405.
  42. Obstein KL, Valdastri P. Advanced endoscopic technologies for colorectal cancer screening. World J Gastroenterol. 2013;19(4):431-439.
  43. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355(18):1863-1872.
  44. Sharma P, Gupta N, Kuipers EJ, Repici A, Wallace M. Advanced imaging in colonoscopy and its impact on quality. Gastrointestinal Endoscopy. 2014;79:1:28-36.
  45. Hazewinkel Y, Dekker E. Colonoscopy: basic principles and novel techniques. Nature Reviews Gastroenterology and Hepatology. 2011;8:10:554-564.
  46. de Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Adenoma detection with cap-assisted colonoscopy versus regular colonoscopy: a randomised controlled trial. Gut. 2012;61:10:1426-1434.
  47. Lee YT, Lai LH, Hui AJ, et al. Efficacy of cap-assisted colonoscopy in comparison with regular colonoscopy: a randomized controlled trial. American Journal of Gastroenterology. 2009;104:1:41-46.
  48. Siersema PD, Rastogi A, Leufkens AM, et al. Retrograde-viewing device improves adenoma detection rate in colonoscopies for surveillance and diagnostic workup. World Journal of Gastroenterology. 2012;18:26:3400-3408.
  49. Leufkens M, Demarco DC, Rastogi A, et al. Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointestinal Endoscopy. 2011;73:3:480-489.
  50. Mamula P, Tierney WM, Banerjee S, et al. Devices to improve colon polyp detection. Gastrointestinal Endoscopy. 2011;73:6:1092-1097.
  51. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Norwegian Colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009;338-343.
  52. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624-1633.
  53. Segnan N, Armaroli P, Bonelli L, et al. SCORE Working Group. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial — SCORE. J Natl Cancer Inst. 2011;103(17):1310-1322
  54. Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Medicine. 2012;9:12:Article ID e1001352.
  55. Rex DK, Adler SN, Aisenberg J, et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology. 2015;148(5):948-957. https://doi.org/10.1053/j.gastro.2015.01.025
  56. Spada C, Hassan C, Munoz-Navas M, et al. Second-generation colon capsule endoscopy compared with colonoscopy. Gastrointest Endosc. 2011;74(3):581-589.
  57. Macari M, Bini EJ. CT colonography: where have we been and where are we going? Radiology. 2005;237(3):819-833.
  58. Sosna J, Sella T, Sy O, et al. Critical analysis of the performance of double-contrast barium enema for detecting colorectal polyps ≥6 mm in the era of CT colonography. The American Journal of Roentgenology. 2008;190:2:374-385.
  59. de Haan MC, Pickhardt PJ, Stoker J. CT colonography: accuracy, acceptance, safety and position in organised population screening. Gut. 2015;64(2):342-350.
  60. Flicek KT, Hara AK, Silva AC, Wu Q, Peter MB, Johnson CD. Reducing the radiation dose for CT colonography using adaptive statistical iterative reconstruction: a pilot study. Am J Roentgenol. 2010;195(1):126-131.
  61. Pickhardt PJ. Incidence of colonic perforation at CT colonography: review of existing data and implications for screening of asymptomatic adults. Radiology. 2006;239(2):313-316.
  62. Zijta FM, Bipat S, Stoker J. Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies. European Radiology. 2010;20:5:1031-1046.
  63. Haykir R, Karakose S, Karabacakoglu A, Sahin M, Kayacetin E. Three-dimensional MR and axial CT colonography versus conventional colonoscopy for detection of colon pathologies. WJ Gastroenterol. 2006;12:15:2345-2350.
  64. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost — effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284(15):1954-1961.
  65. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost — effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(2):96-104.
  66. van Rossum LG, van Rijn AF, Verbeek AL, et al. Colorectal cancer screening comparing no screening, immunochemical and guaiac faecal occult blood tests: a cost — effectiveness analysis. Int J Cancer. 2011;128(8):1908-1917.
  67. Provenzale D. Cost — effectiveness of screening the average-risk population for colorectal cancer. Gastrointest Endosc Clin N Am. 2002;12(1):93-109.
  68. Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, et al. Cost — effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst. 2010;102(16):1238-1252.
  69. Heitman SJ, Hilsden RJ, Au F, Dowden S, Manns BJ. Colorectal cancer screening for average-risk North Americans: an economic evaluation. PLoS Med. 2010;7(11):1000370.
  70. Health Information and Quality Authority. Health technology assessment (HTA) of a population-based colorectal cancer screening programme in Ireland. HIQA, Cork, Ireland. 2009.
  71. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost — effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(2):96-104.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.